SCHEMBL3342912

SCHEMBL3342912

CC(Sc1nc(N)c(C#N)c(-c2ccc(OCCO)cc2)c1C#N)c1cccc(C(=O)O)c1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 16/20 0.88
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
HSD17B10 Q99714 3/20 0.51
MEN1 O00255 3/20 0.51
MAPT P10636 3/20 0.51
KMT2A Q03164 3/20 0.51
HPGD P15428 2/20 0.51
USP2 O75604 1/20 0.51
TP53 P04637 1/20 0.51
ALOX15 P16050 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ADORA2A P29274 1/20 0.51
NPSR1 Q6W5P4 3/20 0.49
POLB P06746 1/20 0.49
TSHR P16473 1/20 0.49
PPARG P37231 1/20 0.49
SMAD3 P84022 1/20 0.49
NCOA2 Q15596 1/20 0.49
NCOA1 Q15788 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15169158 1.00 ADORA1 (0.88) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL10148502 0.94 ADORA1 (0.77) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL244768 0.93 ADORA1 (1.00) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL3375180 0.93 ADORA1 (1.00) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL15169432 0.92 ADORA1 (0.85) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL3343316 0.92 ADORA1 (0.85) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL3337662 0.91 ADORA1 (1.00) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL244759 0.91 ADORA1 (1.00) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL247040 0.87 ADORA1 (0.88) ADORA1KDM4EALDH1A1HSD17B10MEN1
SCHEMBL3366413 0.86 ADORA1 (0.78) ADORA1KDM4EALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-12 US disclosed
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-12 US disclosed
US-9187428-B2 Substituted dicyanopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-17 US disclosed
US-9187428-B2 Substituted dicyanopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-17 US disclosed
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-15 US disclosed
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-15 US disclosed
WO-2012000945-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885KDM4E 1801/4885ALDH1A1 1442/4885
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885KDM4E 1801/4885ALDH1A1 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.